Skip to main content
VA Author Manuscripts logoLink to VA Author Manuscripts
. Author manuscript; available in PMC: 2022 Apr 9.
Published in final edited form as: Life Sci. 2021 Jul 20;284:119845. doi: 10.1016/j.lfs.2021.119845

Acute gene expression changes in the mouse hippocampus following a combined Gulf War toxicant exposure

Kathleen E Murray a,c,1, Vedad Delic a,c,e,2, Whitney A Ratliff d,3, Kevin D Beck b,c,e,4, Bruce A Citron a,c,d,e,*,2
PMCID: PMC8994630  NIHMSID: NIHMS1790908  PMID: 34293396

Abstract

Aims:

Approximately 30% of the nearly 700,000 Veterans who were deployed to the Gulf War from 1990 to 1991 have reported experiencing a variety of symptoms including difficulties with learning and memory, depression and anxiety, and increased incidence of neurodegenerative diseases. Combined toxicant exposure to acetylcholinesterase (AChE) inhibitors has been studied extensively as a likely risk factor. In this study, we modeled Gulf War exposure in male C57Bl/6J mice with simultaneous administration of three chemicals implicated as exposure hazards for Gulf War Veterans: pyridostigmine bromide, the anti-sarin prophylactic; chlorpyrifos, an organophosphate insecticide; and the repellant N,N-diethyl-m-toluamide (DEET).

Main methods:

Following two weeks of daily exposure, we examined changes in gene expression by whole transcriptome sequencing (RNA-Seq) with hippocampal isolates. Hippocampal-associated spatial memory was assessed with a Y-maze task. We hypothesized that genes important for neuronal health become dysregulated by toxicant-induced damage and that these detrimental inflammatory gene expression profiles could lead to chronic neurodegeneration.

Key findings:

We found dysregulation of genes indicating a pro-inflammatory response and downregulation of genes associated with neuronal health and several important immediate early genes (IEGs), including Arc and Egr1, which were both reduced approximately 1.5-fold. Mice exposed to PB + CPF + DEET displayed a 1.6-fold reduction in preference for the novel arm, indicating impaired spatial memory.

Significance:

Differentially expressed genes observed at an acute timepoint may provide insight into the pathophysiology of Gulf War Illness and further explanations for chronic neurodegeneration after toxicant exposure.

Keywords: Gulf War, RNA-Seq, Gene expression, Pyridostigmine bromide, Chlorpyrifos, DEET, Arc, Immediate early genes, Hippocampus

1. Introduction

Gulf War Illness (GWI) is a chronic multi-system disorder affecting approximately 30% of Veterans deployed during Operations Desert Shield and Desert Storm from August 1990 to February 1991 [15]. GWI encompasses a wide spectrum of symptoms which typically include some combination of fatigue/sleep problems, pain, neurological/mood/cognitive impairments, respiratory complaints, gastrointestinal problems, or skin symptoms [6,7]. Of particular interest are neurocognitive impairments and effects on the central nervous system (CNS), as Gulf War Veterans have significantly higher rates of neurological disorders, including amyotrophic lateral sclerosis (ALS), brain cancers, stroke, migraines, neuritis, and neuralgia, than other veteran populations [7]. Research findings in Gulf War animal models have demonstrated that a wide array of physiological alterations including changes in behavior, cognition, neurotransmission, axonal transport, genomic, proteomic, lipidomic, and metabolomic profiling, and mitochondrial dysfunction result from Gulf War exposure [15,7,8].

Military personnel deployed during the Gulf War were exposed to an array of chemical exposures in tandem, particularly acetylcholinesterase (AChE) inhibitors. Investigations into the effects of combined Gulf War exposures vary widely but typically include some combination of insecticides, insect repellants, nerve agents, and anti-toxins against nerve agents [13,7]. Our Gulf War toxicant mixture includes chemicals from three of the most frequently investigated of these classes: specifically, pyridostigmine bromide (PB, a reversible AChE inhibitor administered as a sarin prophylactic), chlorpyrifos (CPF, an organophosphate pesticide), and N,N-diethyl-m-toluamide (DEET, a common insect repellent).

Significant pathological changes in the hippocampus and corresponding impairments in hippocampal-dependent learning and memory have been observed in several animal models of Gulf War toxicant exposure. Rats exposed to low doses of DEET, permethrin, PB, and restraint stress for four weeks showed significantly reduced hippocampal volume and neuron growth as well as increased occurrence of activated microglia and astrocyte hypertrophy which was accompanied by spatial learning and memory dysfunction [9]. The combination of PB and DEET has been shown to influence cholinesterase activity in the rodent brain and affect seizures [10,11]. Organophosphate exposure has also been shown to impair spatial navigation learning in the Morris Water Maze task [12,13]. Neurotoxicity following administration of PB + CPF + DEET was originally reported by Abou-Donia et al. in hens exposed to 5 mg/kg PB i.o., 10 mg/kg CPF s.c., and 500 mg/kg DEET s.c. 5 days/week for 2 months [14]. Ojo et al. reported significant pathological changes in the hippocampus and cortex of C57Bl/6 mice exposed to PB + CPF + permethrin at an acute timepoint (72 h post-exposure) [15].

Transcriptional changes after Gulf War toxicant exposure in rodent models have mostly focused on epigenetic changes or investigation of specific gene categories of interest at chronic timepoints [8,1619]. We assessed acute changes in gene expression in mouse hippocampal RNA isolates after exposure to a combined subcutaneous (s.c.) injection of PB, CPF, and DEET for two weeks using whole transcriptome sequencing (RNA-Seq). We focused on genes important for neuronal health, those that could affected by toxicants, and those involved in inflammatory responses. Differentially expressed genes observed at an acute timepoint may set the stage for chronic outcomes and should provide insight into the pathophysiology of Gulf War Illness and help identify potential targets for future treatment.

2. Materials and methods

2.1. Chemicals

HPLC-grade pyridostigmine bromide (PB, P9797) and N,N-diethyl-m-toluamide (DEET, D100951) were obtained from Sigma-Aldrich (St. Louis, MO). Chlorpyrifos (CPF, N-11459) was obtained from Chem-Service, Inc. (West Chester, PA). The toxicant mixture stock was prepared and stored in 500 μL aliquots at −20 °C until use and diluted in PBS immediately prior to injection. Vehicle for injection contained 3.125% dimethyl sulfoxide (DMSO, 99.9%, D2438-5X10ML) obtained from Thermo Fisher Scientific (Waltham, MA) in 1x PBS.

2.2. Subjects

All animal experiments were performed in accordance with the guidelines of the institution, the National Institutes of Health guide for the Care and Use of Laboratory Animals and approved by the East Orange VA and Bay Pines VA Institutional Animal Care and Use Committees. Animals were single-housed in a 22 °C ± 0.5 °C temperature-controlled environment with a 12-hour light/dark cycle. Animals were allowed a 7-day acclimation period before switching to a reverse light cycle (i.e., dark cycle from 10 am-10 pm) for 5 days prior to exposure. Food and water were available ad libitum throughout for all animals.

2.3. Toxicant exposure

Male C57Bl/6 J mice were obtained from Charles River (Wilmington, MA) for RNA-Seq (n = 6/group) and from Jackson Laboratory (Bar Harbor, ME) for behavior (n = 6/group) based on availability. Mice received daily s.c. injections of either the toxicant mixture containing 2.5 mg/kg PB, 12.5 mg/kg CPF, and 7.5 mg/kg DEET with 3.125% DMSO in PBS or vehicle containing 3.125% DMSO in PBS five days a week (M-F) for two weeks beginning at 12 weeks of age. Adverse effects including seizures resulting in removal and euthanasia, were observed at 1.5- and 2.0-fold higher dosages, but this was extremely rare at the dosage used in this study. Experimental cohorts which generated RNA-seq and behavioral data did not display any significant adverse effects. For RNA-Seq, mice were sacrificed 2–4 h after the final exposure via cervical dislocation and decapitation. Whole brains were immediately extracted, and hippocampal tissue from each hemisphere was dissected and snap frozen on dry ice. All fresh frozen tissue samples were stored at −70 °C until use.

2.4. Y-maze task with preference index

To assess hippocampal-dependent memory, subjects underwent a modified Y-maze task 2–4 h after the final exposure. During the training phase, either Arm B or C (novel arm) was blocked off with a barrier. The novel arm was randomly assigned for each trial. Mice were placed in the start arm (Arm A) of the Y-maze facing the wall and allowed to explore the start and familiar arms for 8 min. Mice were then removed from the maze and returned to their home cage for an intertrial interval of 30 min. During the trial phase, the barrier was removed so that all three arms were accessible. Mice were again placed in the start arm and allowed to explore the start and familiar arms for 8 min. Behavior was captured with a video camera (DMK 22AUC03, The Imaging Source, Charlotte, NC) and recorded by ANY-maze (version 6.17, Stoelting, Wood Dale, IL). Time or entry into a zone was scored based on the center point of the animal’s body. All Y-maze trials were performed under red light during the dark cycle.

2.5. RNA isolation

Hippocampal RNA was isolated by TRIzol (Invitrogen, Waltham, MA) extraction followed by cleanup with a RNeasy Mini Kit (QIAGEN, Hilden, Germany). Tissue was resuspended in 0.4 mL TRIzol and homogenized with a Polytron homogenizer (Kinematica USA, Bohemia, NY) on ice for 30–45 s. Samples were incubated at 23 °C for 5 min before adding 80 μL CHCl3 and vortexing for 15 s. Samples were incubated at 23 °C again for 2–3 min. Tubes were centrifuged at 12,000 rcf for 10 min, and the supernatant was transferred into a new tube with an equal volume of 70% EtOH. RNeasy Mini Kit was then used per the manufacturer’s instructions with Tris-EDTA buffer (TE, pH 8.0, AM9858, Invitrogen) for the final elution step. All RNA isolates were stored at −20 °C until use.

2.6. RNA-Seq

RNA isolates were sequenced by the Rutgers-New Jersey Medical School Genomics Center. Total cellular RNA was qualified by confirming integrity with a 2200 TapeStation (Agilent Technologies, Santa Clara, CA). Samples with an RNA integrity number (RIN) > 7.0 were used for subsequent processing. Total RNAs were subjected to two rounds of poly (A) selection using Oligo d(T)25 Magnetic Beads (New England Biolabs, Ipswich, MA). RNA-Seq libraries were prepared using an NEBNext Ultra RNA Library Prep Kit for Illumina (New England Biolabs). cDNA libraries were purified with AMPure XP beads (Beckman Coulter, Brea, CA) and quantified using a Qubit 4 Fluorometer (Thermo Fisher Scientific). Equimolar amounts of barcoded libraries were pooled and sequenced on a NextSeq 500 Sequencing System (Illumina, San Diego, CA) with a 1 × 75 configuration.

2.7. RNA-Seq analysis

RNA-Seq reads were imported into CLC Genomics Workbench (version 20.0.3, QIAGEN) for preliminary analysis using a modified version of the workflow for RNA-Seq analysis with export to IPA (Fig. 1). All reads were batch processed and mapped to the Mus musculus reference genome. Control vs. PB + CPF + DEET samples were quantified using the Differential Analysis for RNA-Seq tool. Differentially expressed genes were considered significant if they met the following criteria: mean reads per kilobase of transcript per million mapped reads (RPKM) > 10.0, fold change in either direction ≥1.2, and p < 0.1. Gene ontology (GO) categories were assigned and analyzed for significance for biological processes, molecular functions, and cellular components using the Gene Set Test tool. GO categories were considered significant if fold change in either direction ≥1.2 and p < 0.05. Significant genes were exported to IPA.

Fig. 1.

Fig. 1.

RNA-Seq analysis workflow with CLC Genomics Workbench and Ingenuity Pathway Analysis. Whole transcriptome sequencing was performed using mouse hippocampal RNA isolates collected 2–4 h after final exposure. Gene expression tracks were analyzed using the Differential Expression for RNA-Seq tool with RPKM >10.0, |FC| ≥ 1.2, and p < 0.1 as criteria for significance. GO enrichment analysis was performed on subset of genes that were significantly dysregulated. Data for significant genes was exported to Ingenuity Pathway Analysis to assess canonical pathways, molecules, diseases and functions, and other relevant information.

Functional analyses were generated using Ingenuity Pathway Analysis (IPA) (QIAGEN). Core analysis was performed on dataset based on RPKM values for genes that met criteria for significance, which generated lists of significant canonical pathways, upstream regulators, associated diseases and functions, and differentially expressed genes. Canonical pathways were based on significant differentially expressed genes, and a pathway itself was considered significant if p < 0.05.

2.8. Statistics

All statistical analyses for behavior were conducted using GraphPad Prism for macOS (version 9.0.0). Mean values for behavioral analyses are depicted ± standard error of the mean (SEM). Data for open field and Y-maze tasks were analyzed using an unpaired t-test with Welch’s correction, and statistical significance was considered when p < 0.05. Entries into each arm during the Y-maze task were analyzed using multiple unpaired t-tests followed by FDR control with the two-stage step-up method of Benjamini, Krieger, and Yekutieli as recommended by GraphPad. Significant fold changes in RNA expression were analyzed by CLC Genomics Workbench using Differential Expression for RNA-Seq as part of the workflow as detailed in Fig. 1.

3. Results

3.1. Effects of Gulf War toxicant exposure on hippocampal-dependent spatial memory in Y-maze task

To assess effects of the exposure on hippocampal-dependent spatial memory, mice underwent a Y-maze task (n = 6/group). Time spent in each arm, number of entries into each arm, and distance travelled were recorded. Preference for the novel arm was significantly lower by 157% in mice exposed to PB + CPF + DEET compared to controls, p = 0.027 (Fig. 2a). The number of entries into the novel arm was also significantly reduced by 33% compared to control mice, p = 0.003 (Fig. 2b). Distance travelled during the test stage was only 12% lower in toxicant-exposed mice compared to controls and therefore did not significantly differ between conditions, p = 0.182 (Fig. 2c).

Fig. 2.

Fig. 2.

(a) Preference for novel arm, (b) number of entries per arm, and (c) distance travelled during trial phase of Y-maze. Hippocampal-dependent spatial memory was assessed by performance on a Y-maze task 2–4 h after final exposure. (a) Preference for the novel arm was significantly lower in mice receiving PB + CPF + DEET (mean = −0.12 ± 0.099) compared to control mice (mean = 0.21 ± 0.073) (t(9.18) = 2.63, p = 0.027). (b) The number of entries into the novel arm was also significantly lower in mice exposed to PB + CPF + DEET (mean = 15.2 ± 1.15) compared to controls (mean = 22.7 ± 1.52) (t(9.31) = 3.95, p = 0.0031). (c) Distance travelled during the test stage did not significantly differ between conditions (PB + CPF + DEET: mean = 26.6 ± 2.32, control: mean = 30.2 ± 0.74, t(6.00) = 1.51, p = 0.18). All results are graphed as mean ± SEM.

3.2. Gene dysregulation after acute exposure to Gulf War toxicants

In the hippocampus, 158 dysregulated genes were identified with the aid of RNA-Seq analysis which met criteria for differential expression in response to Gulf War toxicant exposure (Fig. 3, Tables 1 and 2). A gene set test (GO enrichment analysis) in CLC Genomics Workbench showed significantly affected gene ontology (GO) categories. Of these categories, 47 were related to biological processes (Table 4a), 138 were related to molecular functions (Table 4b), and 120 were related to cellular components (Table 4c). Pathway analysis in IPA showed 45 significantly affected canonical pathways (Table 3).

Fig. 3.

Fig. 3.

Differentially expressed genes identified by RNA-Seq analysis. Sequence counts from the RNA samples were evaluated with CLC Genomics Workbench and Ingenuity Pathway Analysis software. 158 dysregulated genes were identified in mice exposed to PB + CPF + DEET vs. controls. Genes were considered to be significantly dysregulated if they met the following criteria: RPKM >10.0, |fold change| ≥ 1.2, p < 0.1. Green = downregulated; red = upregulated.

Table 1.

Downregulated genes after exposure to Gulf War insult. Green, negative fold changes indicate downregulation.

Symbol Entrez Gene Name RPKM FC P-value
Arc Activity regulated cytoskeleton associated protein 33.6 −1.553 8.72E-05
Egr1 Early growth response 1 23.3 −1.497 9.77E-05
Nr4a1 Nuclear receptor subfamily 4 group A member 1 16.5 −1.449 0.000608
Apod Apolipoprotein D 32.5 −1.353 0.000973
Hba-a2 Hemoglobin alpha, adult chain 2 60.7 −1.350 0.00485
Tmem88b Transmembrane protein 88B 16.5 −1.350 0.00107
Wfs1 Wolframin ER transmembrane glycoprotein 33.2 −1.321 0.00357
Junb JunB proto-oncogene, AP-1 transcription factor subunit 36.6 −1.308 0.00847
Fam163b Family with sequence similarity 163 member B 52.3 −1.306 0.00959
Mog Myelin oligodendrocyte glycoprotein 22.7 −1.288 0.00659
Mbp Myelin basic protein 281.4 −1.284 0.0115
Bcas1 Breast carcinoma amplified sequence 1 41.5 −1.277 0.00483
Cd9 CD9 molecule 29.2 −1.268 0.0134
Gsn Gelsolin 15.9 −1.267 0.0138
Pllp Plasmolipin 21.3 −1.267 0.018
Mag Myelin associated glycoprotein 50.6 −1.263 0.00963
Nutf2-ps1 Nuclear transport factor 2, pseudogene 1 19.1 −1.263 0.0167
Pcp4l1 Purkinje cell protein 4-like 1 26.7 −1.263 0.0239
H2-D1 Histocompatibility 2, D region locus 1 11.8 −1.259 0.0115
Trf Transferrin 62.8 −1.257 0.0107
Rpl10-ps3 Ribosomal protein L10, pseudogene 3 75.6 −1.255 0.0296
Plekhb1 Pleckstrin homology domain containing B1 65.3 −1.254 0.00647
Srebf1 Sterol regulatory element binding transcription factor 1 11.2 −1.247 0.017
Cnp 2’,3’-cyclic nucleotide 3’ phosphodiesterase 105.7 −1.246 0.0137
Septin4 Septin 4 27.6 −1.244 0.0125
Slco1c1 Solute carrier organic anion transporter family member 1C1 11.2 −1.243 0.0349
Pltp Phospholipid transfer protein 21.6 −1.242 0.0352
Cldn11 Claudin 11 73.5 −1.240 0.0169
Fa2h Fatty acid 2-hydroxylase 11.0 −1.239 0.0267
Rhog Ras homolog family member G 12.3 −1.238 0.0359
Prr18 Proline rich 18 17.0 −1.229 0.0231
Egr4 Early growth response 4 16.8 −1.228 0.0849
mt-Atp8 ATP synthase F0 subunit 8 7509.7 −1.225 0.0323
C1ql2 Complement C1q like 2 40.4 −1.222 0.0578
Nfkbia NFKB inhibitor alpha 12.4 −1.221 0.0608
Igfbp5 Insulin like growth factor binding protein 5 23.2 −1.219 0.0112
B2m Beta-2-microglobulin 57.4 −1.217 0.0348
Hbb-bs Hemoglobin subunit beta 45.2 −1.215 0.0521
S100a16 S100 calcium binding protein A16 20.3 −1.211 0.0518
mt-Atp6 ATP synthase F0 subunit 6 8936.0 −1.210 0.0481
Slc6a6 Solute carrier family 6 member 6 15.6 −1.208 0.0185
Ddit4 DNA damage inducible transcript 4 38.8 −1.204 0.0563
Anxa5 Annexin A5 15.5 −1.203 0.0383
S100a1 S100 calcium binding protein A1 35.3 −1.202 0.0469
Chrm3 Cholinergic receptor muscarinic 3 10.5 −1.200 0.0652

Table 2.

Upregulated genes after exposure to Gulf War insult. Red, positive fold changes indicate upregulation.

Symbol Entrez Gene Name RPKM FC P-value
Lars2 Leucyl-tRNA synthetase 2, mitochondrial 744.328 1.542 4.48E-05
Gdf1 Growth differentiation factor 1 11.348 1.454 0.0081
Cdr1 Cerebellar degeneration related antigen 1 23.178 1.441 0.017
Fam126b Family with sequence similarity 126 member B 12.032 1.390 0.0548
Pak3 p21 (RAC1) activated kinase 3 14.277 1.387 0.00816
Igip IgA inducing protein 31.362 1.377 0.0179
Pgm2l1 Phosphoglucomutase 2 like 1 45.308 1.376 0.0244
Smc3 Structural maintenance of chromosomes 3 11.216 1.367 0.0357
Dgkb Diacylglycerol kinase beta 20.952 1.365 0.0343
Atrx ATRX chromatin remodeler 10.147 1.359 0.0912
Ppp4r2 Protein phosphatase 4 regulatory subunit 2 14.623 1.359 0.0345
Ankrd12 Ankyrin repeat domain 12 10.712 1.357 0.0856
Hspa4l Heat shock protein family A (Hsp70) member 4 like 12.354 1.357 0.0544
Ppig Peptidylprolyl isomerase G 11.563 1.354 0.0353
Rabep1 Rabaptin, RAB GTPase binding effector protein 1 16.266 1.345 0.019
Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 11.871 1.343 0.0384
Pcmtd1 Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 16.76 1.340 0.0856
Reps2 RALBP1 associated Eps domain containing 2 21.405 1.340 0.034
Ube2q2 Ubiquitin conjugating enzyme E2 Q2 13.79 1.332 0.0259
Rab3c RAB3C, member RAS oncogene family 44.551 1.330 0.0242
Acbd5 Acyl-CoA binding domain containing 5 11.406 1.326 0.0703
Fmr1 FMRP translational regulator 1 11.502 1.324 0.0571
Tax1bp1 Tax1 binding protein 1 22.074 1.320 0.0419
Nus1 NUS1 dehydrodolichyl diphosphate synthase subunit 16.346 1.319 0.0104
Hsp90aa1 Heat shock protein 90 alpha family class A member 1 213.841 1.318 0.0268
Gmfb Glia maturation factor beta 35.439 1.317 0.0425
Gpbp1 GC-rich promoter binding protein 1 17.787 1.313 0.0663
Naa50 N(alpha)-acetyltransferase 50, NatE catalytic subunit 16.618 1.312 0.0269
Gabra2 Gamma-aminobutyric acid type A receptor alpha2 subunit 36.465 1.309 0.0647
Fxr1 FMR1 autosomal homolog 1 11.598 1.308 0.0792
Kpna3 Karyopherin subunit alpha 3 16.133 1.308 0.0695
Ipo7 Importin 7 17.7 1.307 0.0853
Mphosph8 M-phase phosphoprotein 8 15.901 1.307 0.027
Kif5b Kinesin family member 5B 33.739 1.305 0.0762
Psd3 Pleckstrin and Sec7 domain containing 3 26.285 1.304 0.0549
Pde1a Phosphodiesterase 1A 26.28 1.298 0.0265
Mob4 MOB family member 4, phocein 14.856 1.297 0.0703
Uba3 Ubiquitin like modifier activating enzyme 3 13.952 1.289 0.086
Slc8a1 Solute carrier family 8 member A1 11.848 1.287 0.0454
Ankrd13c Ankyrin repeat domain 13C 19.116 1.286 0.0179
Pten Phosphatase and tensin homolog 20.14 1.286 0.0542
Eif3a Eukaryotic translation initiation factor 3 subunit A 27.913 1.284 0.0128
Gabrb1 Gamma-aminobutyric acid type A receptor beta1 subunit 13.845 1.282 0.0663
Ogfrl1 Opioid growth factor receptor like 1 36.947 1.277 0.0141
Selenot Selenoprotein T 44.851 1.277 0.0616
Eif5 Eukaryotic translation initiation factor 5 34.859 1.276 0.0662
Htatsf1 HIV-1 Tat specific factor 1 18.843 1.275 0.0447
Top1 DNA topoisomerase I 22.617 1.275 0.0196
Slc25a46 Solute carrier family 25 member 46 11.765 1.272 0.084
Nrxn1 Neurexin 1 30.941 1.269 0.0682
Gad2 Glutamate decarboxylase 2 17.309 1.268 0.0356
Fgfr1op2 FGFR1 oncogene partner 2 25.756 1.267 0.0296
Hspa5 Heat shock protein family A (Hsp70) member 5 46.918 1.267 0.00428
Zc3h15 Zinc finger CCCH-type containing 15 34.721 1.266 0.0177
Armcx3 Armadillo repeat containing X-linked 3 22 1.264 0.0541
Hnrnpa3 Heterogeneous nuclear ribonucleoprotein A3 29.364 1.263 0.0946
Senp6 SUMO specific peptidase 6 10.207 1.263 0.0819
Fbxo11 F-box protein 11 23.116 1.261 0.062
Cert1 Ceramide transporter 1 11.829 1.257 0.0968
Oxr1 Oxidation resistance 1 23.222 1.257 0.0785
Impact Impact RWD domain protein 38.33 1.252 0.0648
Psip1 PC4 and SFRS1 interacting protein 1 32.895 1.252 0.0289
Slmap Sarcolemma associated protein 13.2 1.252 0.0502
Fgf12 Fibroblast growth factor 12 10.635 1.249 0.0679
Sucla2 Succinate-CoA ligase ADP-forming beta subunit 33.008 1.249 0.0601
Dld Dihydrolipoamide dehydrogenase 28.74 1.248 0.0389
Negr1 Neuronal growth regulator 1 18.551 1.246 0.0251
Acsl4 Acyl-CoA synthetase long chain family member 4 13.462 1.242 0.0806
Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 37.903 1.242 0.0162
Pnrc2 Proline rich nuclear receptor coactivator 2 13.435 1.242 0.0808
Eif5b Eukaryotic translation initiation factor 5B 11.453 1.240 0.0354
Mib1 Mindbomb E3 ubiquitin protein ligase 1 15.309 1.239 0.0985
Plcb1 Phospholipase C beta 1 19.494 1.239 0.0438
Map9 Microtubule associated protein 9 15.383 1.238 0.0815
Jakmip2 Janus kinase and microtubule interacting protein 2 11.357 1.236 0.0491
Pura Purine rich element binding protein A 19.084 1.236 0.019
Hsp90b1 Heat shock protein 90 beta family member 1 65.468 1.235 0.027
Ncl Nucleolin 18.087 1.235 0.0652
Neto1 Neuropilin and tolloid like 1 16.105 1.233 0.0711
Gda Guanine deaminase 30.573 1.232 0.0364
Cnr1 Cannabinoid receptor 1 25.574 1.231 0.0575
Bhlhb9 Basic helix-loop-helix family member b9 16.07 1.229 0.0355
Ythdc1 YTH domain containing 1 13.542 1.228 0.0578
Golga4 Golgin A4 10.017 1.226 0.0576
Cir1 Corepressor interacting with RBPJ, 1 10.903 1.224 0.0657
Mzt1 Mitotic spindle organizing protein 1 27.367 1.224 0.0631
Rnf6 Ring finger protein 6 10.488 1.224 0.0599
Gdap1 Ganglioside induced differentiation associated protein 1 20.359 1.223 0.0596
Lpgat1 Lysophosphatidylglycerol acyltransferase 1 20.943 1.221 0.0473
Pin4 Peptidylprolyl cis/trans isomerase, NIMA-interacting 4 14.967 1.221 0.085
Cpne7 Copine 7 93.847 1.220 0.0478
Ggnbp2 Gametogenetin binding protein 2 18.355 1.216 0.0902
Etv1 ETS variant transcription factor 1 14.066 1.215 0.0518
Arl5a ADP ribosylation factor like GTPase 5A 15.424 1.214 0.0924
Pafah1b1 Platelet activating factor acetylhydrolase 1b regulatory subunit 1 59.969 1.213 0.0964
Tafa1 TAFA chemokine like family member 1 11.298 1.213 0.0663
Srsf3 Serine and arginine rich splicing factor 3 27.672 1.212 0.044
Tceal9 Transcription elongation factor A like 9 29.46 1.212 0.0939
Ccdc47 Coiled-coil domain containing 47 14.385 1.211 0.0885
Tim2 Tripartite motif containing 2 46.277 1.211 0.072
Aff4 AF4/FMR2 family member 4 15.746 1.210 0.093
C5orf24 Chromosome 5 open reading frame 24 18.903 1.210 0.0917
Msantd4 Myb/SANT DNA binding domain containing 4 with coiled-coils 14.084 1.208 0.0552
Rab39b RAB39B, member RAS oncogene family 10.444 1.208 0.087
Vxn Vexin 56.093 1.207 0.0472
Tmem33 Transmembrane protein 33 10.859 1.205 0.0876
Slk STE20 like kinase 10.826 1.204 0.0747
Hdgfl3 HDGF like 3 11.325 1.202 0.0891
Dynlt3 Dynein light chain Tctex-type 3 39.421 1.201 0.0859
Dyrk2 Dual specificity tyrosine phosphorylation regulated kinase 2 10.698 1.200 0.0429

Table 4a.

Subset of significantly affected gene ontology categories involved in biological processes. Green, negative fold changes indicate downregulation. Red, positive fold changes indicate upregulation.

GO term Description Detected Genes DE Genes DE Genes (Names) P-values
0110077 Vesicle-mediated intercellular transport 1 1 Arc 2.89E-4
0006429 Leucyl-tRNA aminoacylation 2 1 Lars2 5.78E-4
0050767 Regulation of neurogenesis 934 3 Arc, Gh, Opalin 1.45E-3
0006518 Peptide metabolic process 262 2 Hmgn5, Lars2 2.22E-3
0090031 Positive regulation of steroid hormone biosynthetic process 9 1 Gh 2.60E-3
2000969 Positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity 9 1 Arc 2.60E-3
0032094 Response to food 12 1 Gh 3.47E-3
0043603 Cellular amide metabolic process 392 2 Hmgn5, Lars2 4.90E-3
1900452 Regulation of long-term synaptic depression 17 1 Arc 4.91E-3
0007405 Neuroblast proliferation 19 1 Gh 5.48E-3
0099149 Regulation of postsynaptic neurotransmitter receptor internalization 23 1 Arc 6.64E-3
0032543 Mitochondrial translation 31 1 Lars2 8.94E-3
0007616 Long-term memory 39 1 Arc 0.0112
0007492 Endoderm development 40 1 Arc 0.0115
0040018 Positive regulation of multicellular organism growth 42 1 Gh 0.0121
0072089 Stem cell proliferation 45 1 Gh 0.0129
0048286 Lung alveolus development 49 1 Gh 0.0141
0048713 Regulation of oligodendrocyte differentiation 49 1 Opalin 0.0141
0010828 Positive regulation of glucose transport 50 1 Gh 0.0144
0051028 mRNA transport 52 1 Arc 0.0149
1900271 Regulation of long-term synaptic potentiation 54 1 Arc 0.0155
0006749 Glutathione metabolic process 55 1 Hmgn5 0.0158
0061001 Regulation of dendritic spine morphogenesis 56 1 Arc 0.0161
0099601 Regulation of neurotransmitter receptor activity 60 1 Arc 0.0172
0061351 Neural precursor cell proliferation 63 1 Gh 0.0181
0048168 Regulation of neuronal synaptic plasticity 69 1 Arc 0.0198
0045685 Regulation of glial cell differentiation 86 1 Opalin 0.0246
0032869 Cellular response to insulin stimulus 87 1 Gh 0.0249
0046889 Positive regulation of lipid biosynthetic process 94 1 Gh 0.0269
0060998 Regulation of dendritic spine development 97 1 Arc 0.0277
0032414 Positive regulation of ion transmembrane transporter activity 114 1 Arc 0.0325
0051260 Protein homooligomerization 116 1 Arc 0.0331
0071375 Cellular response to peptide hormone stimulus 119 1 Gh 0.0340
0006575 Cellular modified amino acid metabolic process 138 1 Hmgn5 0.0393
0014013 Regulation of gliogenesis 148 1 Opalin 0.0421
1901564 Organonitrogen compound metabolic process 1208 2 Hmgn5, Lars2 0.0423
0010469 Regulation of receptor activity 156 1 Arc 0.0443
0009952 Anterior/posterior pattern specification 170 1 Arc 0.0482
0043604 Amide biosynthetic process 214 1 Lars2 0.0604
0043933 Macromolecular complex subunit organization 1504 2 Arc, Hmgn5 0.0633
1901215 Negative regulation of neuron death 244 1 Gh 0.0686
0032412 Regulation of ion transmembrane transporter activity 249 1 Arc 0.0700
0006790 Sulfur compound metabolic process 271 1 Hmgn5 0.0760
0009416 Response to light stimulus 288 1 Gh 0.0806
0050890 Cognition 325 1 Arc 0.0905
0010769 Regulation of cell morphogenesis involved in differentiation 344 1 Arc 0.0956
0007005 Mitochondrion organization 345 1 Lars2 0.0959
0071417 9
Cellular response to organonitrogen compound
347 1 Gh 0.0964

Table 4b.

Subset of significantly affected gene ontology categories involved in molecular functions. Green, negative fold changes indicate downregulation. Red, positive fold changes indicate upregulation.

GO term Description Detected Genes DE Genes DE Genes (Names) P-values
0033592 RNA strand annealing activity 3 2 Fmr1, Fxr1 2.18E-04
0097100 Supercoiled DNA binding 3 2 Psip1, Top1 2.18E-04
0070840 Dynein complex binding 21 3 Fmr1, Pafah1b1, Smc3 7.32E-04
0051082 Unfolded protein binding 61 4 Dnajb4, Hsp90aa1, Hsp90b1, Hspa5 1.85E-03
0002151 G-quadruplex RNA binding 9 2 Fmr1, Fxr1 2.52E-03
0062061 TAP complex binding 9 2 H2-D1, H2-K1 2.52E-03
0031720 Haptoglobin binding 9 2 Hba-a2, Hbb-bs 2.52E-03
0019911 Structural constituent of myelin sheath 10 2 Mbp, Pllp 3.14E-03
0030881 Beta-2-microglobulin binding 11 2 H2-D1, H2-K1 3.81E-03
0042610 CD8 receptor binding 11 2 H2-D1, H2-K1 3.81E-03
0046977 TAP binding 11 2 H2-D1, H2-K1 3.81E-03
0003743 Translation initiation factor activity 38 3 Eif3a, Eif5, Eif5b 4.18E-03
1990825 Sequence-specific mRNA binding 13 2 Fmr1, Srsf3 5.35E-03
0022851 GABA-gated chloride ion channel activity 13 2 Gabra2, Gabrb1 5.35E-03
0097001 Ceramide binding 14 2 Mag, Pltp 6.20E-03
0042608 T cell receptor binding 15 2 H2-D1, H2-K1 7.12E-03
0004113 2’,3’-cyclic-nucleotide 3’-phosphodiesterase activity 1 1 Cnp 8.57E-03
0004148 Dihydrolipoyl dehydrogenase activity 1 1 Dld 8.57E-03
0043544 Lipoamide binding 1 1 Dld 8.57E-03
0080132 Fatty acid alpha-hydroxylase activity 1 1 Fa2h 8.57E-03
0008892 Guanine deaminase activity 1 1 Gda 8.57E-03
0052858 Peptidyl-lysine acetyltransferase activity 1 1 Naa50 8.57E-03
1990631 ErbB-4 class receptor binding 1 1 Ncl 8.57E-03
0047933 Glucose-1,6-bisphosphate synthase activity 1 1 Pgm2l1 8.57E-03
0140339 Phosphatidylglycerol transfer activity 1 1 Pltp 8.57E-03
0140340 Cerebroside transfer activity 1 1 Pltp 8.57E-03
0140337 Diacylglyceride transfer activity 1 1 Pltp 8.57E-03
0140338 Sphingomyelin transfer activity 1 1 Pltp 8.57E-03
0051717 Inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity 1 1 Pten 8.57E-03
0051800 Phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity 1 1 Pten 8.57E-03
0001761 Beta-alanine transmembrane transporter activity 1 1 Slc6a6 8.57E-03
0005369 Taurine:sodium symporter activity 1 1 Slc6a6 8.57E-03
0004890 GABA-A receptor activity 18 2 Gabra2, Gabrb1 0.010198
0019825 Oxygen binding 18 2 Hba-a2, Hbb-bs 0.010198
0031489 Myosin V binding 20 2 Rab39b, Rab3c 0.012524
0043022 Ribosome binding 57 3 Fmr1, Hspa5, Impact 0.01287
0008139 Nuclear localization sequence binding 21 2 Kpna3, Nfkbia 0.013765
0005104 Fibroblast growth factor receptor binding 22 2 Fgf12, Nrxn1 0.015057
0001671 ATPase activator activity 23 2 Dnaja1, Dnajb4 0.0164
0004351 Glutamate decarboxylase activity 2 1 Gad2 0.017065
0031722 Hemoglobin beta binding 2 1 Hbb-bs 0.017065
0002135 CTP binding 2 1 Hsp90aa1 0.017065
0099609 Microtubule lateral binding 2 1 Kif5b 0.017065
0004823 Leucine-tRNA ligase activity 2 1 Lars2 0.017065
0045547 Dehydrodolichyl diphosphate synthase activity 2 1 Nus1 0.017065
0120019 Phosphatidylcholine transfer activity 2 1 Pltp 0.017065
0030977 Taurine binding 2 1 Slc6a6 0.017065
0086038 Calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential 2 1 Slc8a1 0.017065
0099580 Ion antiporter activity involved in regulation of postsynaptic membrane potential 2 1 Slc8a1 0.017065
0032810 Sterol response element binding 2 1 Srebf1 0.017065
0004775 Succinate-CoA ligase (ADP-forming) activity 2 1 Sucla2 0.017065
0034986 Iron chaperone activity 2 1 Trf 0.017065
0019781 NEDD8 activating enzyme activity 2 1 Uba3 0.017065
0048027 mRNA 5’-UTR binding 24 2 Fmr1, Ncl 0.017791
0044183 Protein folding chaperone 26 2 Hsp90aa1, Hspa5 0.020718
0035064 Methylated histone binding 70 3 Atrx, Fmr1, Mphosph8 0.022223
0048306 Calcium-dependent protein binding 70 3 Nrxn1, S100a1, Wfs1 0.022223
0042605 Peptide antigen binding 27 2 H2-D1, H2-K1 0.022251
0042165 Neurotransmitter binding 28 2 Chrm3, Slc6a6 0.02383
0050750 Low-density lipoprotein particle receptor binding 28 2 Dnaja1, Hsp90b1 0.02383
0008081 Phosphoric diester hydrolase activity 72 3 Cnp, Pde1a, Plcb1 0.023917
0004949 Cannabinoid receptor activity 3 1 Cnr1 0.025489
0044729 Hemi-methylated DNA-binding 3 1 Egr1 0.025489
0051033 RNA transmembrane transporter activity 3 1 Hnrnpa3 0.025489
0017098 Sulfonylurea receptor binding 3 1 Hsp90aa1 0.025489
1905576 Ganglioside GT1b binding 3 1 Mag 0.025489
0042134 rRNA primary transcript binding 3 1 Ncl 0.025489
0004719 Protein-L-isoaspartate (D-aspartate) O-methyltransferase activity 3 1 Pcmtd1 0.025489
0048101 Calcium-and calmodulin-regulated 3’,5’-cyclic-GMP phosphodiesterase activity 3 1 Pde1a 0.025489
0004117 Calmodulin-dependent cyclic-nucleotide phosphodiesterase activity 3 1 Pde1a 0.025489
0003681 Bent DNA binding 3 1 Pin4 0.025489
0016314 Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity 3 1 Pten 0.025489
0070139 SUMO-specific endopeptidase activity 3 1 Senp6 0.025489
1905060 Calcium:cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration 3 1 Slc8a1 0.025489
0003917 DNA topoisomerase type I activity 3 1 Top1 0.025489
0071074 Eukaryotic initiation factor eIF2 binding 4 1 Eif5 0.033841
0031721 Hemoglobin alpha binding 4 1 Hbb-bs 0.033841
0032564 dATP binding 4 1 Hsp90aa1 0.033841
0032551 Pyrimidine ribonucleoside binding 4 1 Hsp90aa1 0.033841
0002134 UTP binding 4 1 Hsp90aa1 0.033841
0044547 DNA topoisomerase binding 4 1 Ncl 0.033841
0097109 Neuroligin family protein binding 4 1 Nrxn1 0.033841
0032422 Purine-rich negative regulatory element binding 4 1 Pura 0.033841
0015349 Thyroid hormone transmembrane transporter activity 4 1 Slco1c1 0.033841
0042162 Telomeric DNA binding 34 2 Ncl, Pura 0.03421
0031369 Translation initiation factor binding 35 2 Eif5, Fmr1 0.036084
0060590 ATPase regulator activity 37 2 Dnaja1, Dnajb4 0.039946
0070087 Chromo shadow domain binding 5 1 Atrx 0.042122
0015616 DNA translocase activity 5 1 Atrx 0.042122
0055131 C3HC4-type RING finger domain binding 5 1 Dnaja1 0.042122
0005131 Growth hormone receptor binding 5 1 Gh 0.042122
0051022 Rho GDP-dissociation inhibitor binding 5 1 Hsp90aa1 0.042122
0005105 Type 1 fibroblast growth factor receptor binding 5 1 Nrxn1 0.042122
0036033 Mediator complex binding 5 1 Smc3 0.042122
0035255 Ionotropic glutamate receptor binding 39 2 Neto1, Pten 0.043957
0047676 Arachidonate-CoA ligase activity 6 1 Acsl4 0.050333
0016907 G-protein coupled acetylcholine receptor activity 6 1 Chrm3 0.050333
0034604 Pyruvate dehydrogenase (NAD+) activity 6 1 Dld 0.050333
0035368 Selenocysteine insertion sequence binding 6 1 Ncl 0.050333
0019992 Diacylglycerol binding 6 1 Pltp 0.050333
1990050 Phosphatidic acid transporter activity 6 1 Pltp 0.050333
1904121 Phosphatidylethanolamine transporter activity 6 1 Pltp 0.050333
0004791 Thioredoxin-disulfide reductase activity 6 1 Selenot 0.050333
0005332 Gamma-aminobutyric acid:sodium symporter activity 6 1 Slc6a6 0.050333
0004601 Peroxidase activity 44 2 Hba-a2, Hbb-bs 0.054596
0099635 Voltage-gated calcium channel activity involved in positive regulation of presynaptic cytosolic calcium levels 7 1 Cnr1 0.058473
0010385 Double-stranded methylated DNA binding 7 1 Egr1 0.058473
0030911 TPR domain binding 7 1 Hsp90aa1 0.058473
1905538 Polysome binding 7 1 Impact 0.058473
1904315 Transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential 47 2 Gabra2, Gabrb1 0.061369
0061797 pH-gated chloride channel activity 48 2 Gabra2, Gabrb1 0.063687
0030235 Nitric-oxide synthase regulator activity 8 1 Hsp90aa1 0.066545
0031995 Insulin-like growth factor II binding 8 1 Igfbp5 0.066545
0010997 Anaphase-promoting complex binding 8 1 Pten 0.066545
1990247 N6-methyladenosine-containing RNA binding 8 1 Ythdc1 0.066545
0008028 Monocarboxylic acid transmembrane transporter activity 52 2 Slc6a6, Slco1c1 0.073247
0031957 Very long-chain fatty acid-CoA ligase activity 9 1 Acsl4 0.074547
0030957 Tat protein binding 9 1 Dnaja1 0.074547
0034046 Poly(G) binding 9 1 Fmr1 0.074547
0003691 Double-stranded telomeric DNA binding 9 1 Pura 0.074547
0005544 Calcium-dependent phospholipid binding 53 2 Anxa5, Cpne7 0.075705
0035197 siRNA binding 10 1 Fmr1 0.082482
0045159 Myosin II binding 10 1 Gsn 0.082482
0043208 Glycosphingolipid binding 10 1 Mag 0.082482
0008199 Ferric iron binding 10 1 Trf 0.082482
0005388 Calcium-transporting ATPase activity 11 1 Anxa5 0.090349
0004143 Diacylglycerol kinase activity 11 1 Dgkb 0.090349
0016274 Protein-arginine N-methyltransferase activity 11 1 Fbxo11 0.090349
0008503 Benzodiazepine receptor activity 11 1 Gabra2 0.090349
0008429 Phosphatidylethanolamine binding 11 1 Pltp 0.090349
1901611 Phosphatidylglycerol binding 11 1 Pltp 0.090349
0005086 ARF guanyl-nucleotide exchange factor activity 11 1 Psd3 0.090349
1990459 Transferrin receptor binding 11 1 Trf 0.090349
0019829 Inorganic cation-transporting ATPase activity 59 2 Anxa5, mt-Atp6 0.09098
0042625 ATPase coupled ion transmembrane transporter activity 61 2 Anxa5, mt-Atp6 0.096257
0000900 Translation repressor activity, mRNA regulatory element binding 12 1 Pura 0.098149
0044548 S100 protein binding 12 1 S100a1 0.098149
0042910 Xenobiotic transporter activity 12 1 Slc6a6 0.098149

Table 4c.

Subset of significantly affected gene ontology categories forming cellular components. Green, negative fold changes indicate downregulation. Red, positive fold changes indicate upregulation.

GO term Description Total Genes DE Genes DE Genes (Names) P-values
0043218 Compact myelin 5 4 Mag, Mbp, Pllp, Pmp22 2.639E-07
0043209 Myelin sheath 182 12 Cldn11, Cnp, Dld, Gjc2, Gsn, Hsp90aa1, Hspa5, Mag, Mbp, Mog, Plcb1, Sucla2 2.427E-05
0035749 Myelin sheath adaxonal region 6 3 Cnp, Mag, Pten 6.830E-05
0000235 Astral microtubule 8 3 Dynlt3, Map9, Pafah1b1 1.869E-04
0098982 GABA-ergic synapse 104 8 Camk4, Cnr1, Gabra2, Gabrb1, Gabrd, Nrxn1, Plcb1, Slc6a6 1.951E-04
1990015 Ensheathing process 2 2 Mag, Myoc 2.329E-04
0097453 Mesaxon 2 2 Mag, Myoc 2.329E-04
0043197 Dendritic spine 181 10 Akap5, Arc, Fmr1, Fxr1, Homer1, Lpar1, Mob4, Pten, Slc8a1, Syndig1 4.823E-04
0043198 Dendritic shaft 69 6 Akap5, Hcn1, Homer1, Lpar1, Slc8a1, Syndig1 6.462E-04
0034663 Endoplasmic reticulum chaperone complex 12 3 Hsp90b1, Hspa5, Sdf2l1 7.018E-04
0042824 MHC class I peptide loading complex 14 3 B2m, H2-D1, H2-K1 1.135E-03
0005790 Smooth endoplasmic reticulum 31 4 Dnajc3, Fmr1, Hsp90b1, Hspa5 1.214E-03
0043220 Schmidt-Lanterman incisure 15 3 Mag, Myoc, Pten 1.403E-03
1902737 Dendritic filopodium 5 2 Fmr1, Fxr1 2.259E-03
0030139 Endocytic vesicle 154 8 Gsn, Kif5b, Lpar1, Nrxn1, Rab8b, Rab9b, Rabep1, Trf 2.573E-03
1990712 HFE-transferrin receptor complex 6 2 B2m, Trf 3.354E-03
0031415 NatA complex 6 2 Naa15, Naa50 3.354E-03
0001651 Dense fibrillar component 6 2 Ncl, Top1 3.354E-03
0042579 Microbody 127 7 Acbd5, Acsl4, Crot, Idi1, Pex13, Pnpla8, Rab8b 3.400E-03
0030670 Phagocytic vesicle membrane 21 3 B2m, H2-D1, H2-K1 3.832E-03
0005797 Golgi medial cisterna 23 3 H2-D1, H2-K1, Yipf6 4.990E-03
0060076 Excitatory synapse 46 4 Akap5, Homer1, Neto1, Syndig1 5.266E-03
0060077 Inhibitory synapse 24 3 Gabra2, Gad2, Nrxn1 5.639E-03
0005844 Polysome 47 4 Fmr1, Fxr1, Impact, Upf2 5.688E-03
0030666 Endocytic vesicle membrane 26 3 B2m, H2-D1, H2-K1 7.083E-03
0099524 Postsynaptic cytosol 26 3 Fmr1, Homer1, Pten 7.083E-03
0005876 Spindle microtubule 51 4 Bod1l, Dynlt3, Map9, Pafah1b1 7.600E-03
0035748 Myelin sheath abaxonal region 9 2 Cnp, Myoc 7.809E-03
0044326 Dendritic spine neck 9 2 Fmr1, Fxr1 7.809E-03
0005833 Hemoglobin complex 9 2 Hba-a2, Hbb-bs 7.809E-03
0051286 Cell tip 10 2 Rab8b, Trf 9.663E-03
0005777 Peroxisome 119 6 Acbd5, Acsl4, Crot, Idi1, Pex13, Pnpla8 9.958E-03
0098845 Postsynaptic endosome 12 2 Akap5, Arc 0.0139
0009898 Cytoplasmic side of plasma membrane 61 4 Akap5, G6pdx, Litaf, Pten 0.0141
1990707 Nuclear subtelomeric heterochromatin 1 1 Atrx 0.0153
0030990 Intraciliary transport particle 1 1 Dync2li1 0.0153
0005969 Serine-pyruvate aminotransferase complex 1 1 Eea1 0.0153
0071540 Eukaryotic translation initiation factor 3 complex, eIF3e 1 1 Eif3a 0.0153
0016028 Rhabdomere 1 1 Mertk 0.0153
0034678 Integrin alpha8-beta1 complex 1 1 Npnt 0.0153
0005943 Phosphatidylinositol 3-kinase complex, class IA 1 1 Pik3ca 0.0153
0045239 Tricarboxylic acid cycle enzyme complex 13 2 Dld, Sucla2 0.0163
1902711 GABA-A receptor complex 13 2 Gabra2, Gabrb1 0.0163
0071556 Integral component of lumenal side of endoplasmic reticulum membrane 13 2 H2-D1, H2-K1 0.0163
1990124 Messenger ribonucleoprotein complex 14 2 Fmr1, Hnrnpa3 0.0188
0005778 Peroxisomal membrane 38 3 Pex13, Pnpla8, Rab8b 0.0201
0032590 Dendrite membrane 39 3 Akap5, Gabra2, Hcn1 0.0215
0098839 Postsynaptic density membrane 39 3 Arc, Neto1, Syndig1 0.0215
0099522 Region of cytosol 40 3 Fmr1, Homer1, Pten 0.0230
0005753 Mitochondrial proton-transporting ATP synthase complex 16 2 mt-Atp6, mt-Atp8 0.0243
0099634 Postsynaptic specialization membrane 41 3 Arc, Neto1, Syndig1 0.0246
0045178 Basal part of cell 17 2 Cldn11, Trf 0.0272
0033270 Paranode region of axon 17 2 Gjc2, Mag 0.0272
0055037 Recycling endosome 113 5 Akap5, Avl9, Eea1, Mctp1, Trf 0.0298
0032433 Filopodium tip 18 2 Fmr1, Fzd3 0.0303
0030140 Trans-Golgi network transport vesicle 18 2 Gopc, Rab8b 0.0303
0072563 Endothelial microparticle 2 1 Anxa5 0.0303
0043614 Multi-eIF complex 2 1 Eif3a 0.0303
0032998 Fc-epsilon receptor I complex 2 1 Fcer1g 0.0303
0061202 Clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane 2 1 Gad2 0.0303
0097226 Sperm mitochondrial sheath 2 1 Hsp90aa1 0.0303
0098560 Cytoplasmic side of late endosome membrane 2 1 Litaf 0.0303
0005818 Aster 2 1 Map9 0.0303
1904423 Dehydrodolichyl diphosphate synthase complex 2 1 Nus1 0.0303
0030426 Growth cone 197 7 Cnr1, Fmr1, Fxr1, Hsp90aa1, Kif5b, Nrxn1, Pafah1b1 0.0321
0044449 Contractile fiber part 198 7 Anxa5, Fxr1, Homer1, Jph1, Npnt, S100a1, Slc8a1 0.0328
0044295 Axonal growth cone 46 3 Hsp90aa1, Kif5b, Nrxn1 0.0331
0090723 Growth cone part 19 2 Fmr1, Pafah1b1 0.0336
0043034 Costamere 19 2 Fxr1, Homer1 0.0336
0005922 Connexin complex 19 2 Gjb1, Gjc2 0.0336
0043679 Axon terminus 121 5 Anxa5, Chrm3, Fmr1, Hcn1, Slc8a1 0.0383
0045335 Phagocytic vesicle 83 4 Gsn, Kif5b, Rab8b, Rab9b 0.0384
0030018 Z disc 124 5 Anxa5, Homer1, Jph1, S100a1, Slc8a1 0.0418
0099055 Integral component of postsynaptic membrane 167 6 Chrm3, Gabra2, Gabrd, Neto1, Slc6a6, Slc8a1 0.0435
0005921 Gap junction 22 2 Gjb1, Gjc2 0.0440
0098855 HCN channel complex 3 1 Hcn1 0.0452
0097524 Sperm plasma membrane 3 1 Hsp90aa1 0.0452
0014701 Junctional sarcoplasmic reticulum membrane 3 1 Jph1 0.0452
0098559 Cytoplasmic side of early endosome membrane 3 1 Litaf 0.0452
0034457 Mpp10 complex 3 1 Mphosph10 0.0452
1990415 Pex17p-Pex14p docking complex 3 1 Pex13 0.0452
0042709 Succinate-CoA ligase complex 3 1 Sucla2 0.0452
0035327 Transcriptionally active chromatin 23 2 Aff4, Psip1 0.0477
0031307 Integral component of mitochondrial outer membrane 24 2 Armcx3, Gdap1 0.0515
0032279 Asymmetric synapse 25 2 Akap5, Chrm3 0.0555
0005868 Cytoplasmic dynein complex 25 2 Dync2li1, Dynlt3 0.0555
0032783 ELL-EAF complex 4 1 Aff4 0.0598
0043159 Acrosomal matrix 4 1 Dld 0.0598
0044308 Axonal spine 4 1 Eea1 0.0598
1990812 Growth cone filopodium 4 1 Fmr1 0.0598
0097444 Spine apparatus 4 1 Fmr1 0.0598
0019034 Viral replication complex 4 1 Fmr1 0.0598
0030478 Actin cap 4 1 Gsn 0.0598
0042567 Insulin-like growth factor ternary complex 4 1 Igfbp5 0.0598
0035976 Transcription factor AP-1 complex 4 1 Junb 0.0598
0098574 Cytoplasmic side of lysosomal membrane 4 1 Litaf 0.0598
0033269 Internode region of axon 4 1 Mbp 0.0598
0031021 Interphase microtubule organizing center 4 1 Mzt1 0.0598
0030289 Protein phosphatase 4 complex 4 1 Ppp4r2 0.0598
0008305 Integrin complex 28 2 Npnt, Pmp22 0.0679
0098563 Intrinsic component of synaptic vesicle membrane 63 3 Gabra2, Rab3c, Wfs1 0.0719
0070971 Endoplasmic reticulum exit site 29 2 H2-D1, H2-K1 0.0722
0031256 Leading edge membrane 146 5 Akap5, Gabra2, Hcn1, Hsp90aa1, Psd3 0.0737
0061673 Mitotic spindle astral microtubule 5 1 Dynlt3 0.0741
0044094 Host cell nuclear part 5 1 Fmr1 0.0741
1990769 Proximal neuron projection 5 1 Gjc2 0.0741
0030485 Smooth muscle contractile fiber 5 1 Npnt 0.0741
0016586 RSC complex 5 1 Pbrm1 0.0741
0034991 Nuclear meiotic cohesin complex 5 1 Smc3 0.0741
0097433 Dense body 5 1 Trf 0.0741
0098984 Neuron to neuron synapse 30 2 Akap5, Chrm3 0.0766
0030672 Synaptic vesicle membrane 66 3 Gad2, Mctp1, Syndig1 0.0802
0005791 Rough endoplasmic reticulum 67 3 Ccdc47, Clock, Fmr1 0.0830
0005726 Perichromatin fibrils 6 1 Clock 0.0883
0031466 Cul5-RING ubiquitin ligase complex 6 1 Cul5 0.0883
0071598 Neuronal ribonucleoprotein granule 6 1 Fmr1 0.0883
0008274 Gamma-tubulin ring complex 6 1 Mzt1 0.0883
0090724 Central region of growth cone 6 1 Pafah1b1 0.0883
0000932 Cytoplasmic mRNA processing body 72 3 Dcp2, Pnrc2, Top1 0.0979
0032040 Small-subunit processome 35 2 Krr1, Mphosph10 0.0997

Table 3.

Significantly affected canonical pathways after Gulf War insult. Green, negative fold changes indicate downregulation. Red, positive fold changes indicate upregulation.

Ingenuity Canonical Pathways −log(p-value) Ratio Molecules
Protein Ubiquitination Pathway 4.08 0.033 B2m, Dnaja1, Dnajb4, Hba-a2, Hsp90aa1, Hsp90b1, Hspa4l, Hspa5, Ube2q2
Aldosterone Signaling in Epithelial Cells 4.07 0.0443 Dnaja1, Dnajb4, Hsp90aa1, Hsp90b1, Hspa4l, Hspa5, Plcb1
Hypoxia Signaling in the Cardiovascular System 3.9 0.0676 Hsp90aa1, Hsp90b1, Nfkbia, Pten, Ube2q2
Mitotic Roles of Polo-Like Kinase 3.03 0.0606 Hsp90aa1, Hsp90b1, Slk, Smc3
Prostate Cancer Signaling 2.51 0.044 Hsp90aa1, Hsp90b1, Nfkbia, Pten
Unfolded protein response 2.23 0.0536 Hsp90b1, Hspa5, Srebf1
Role of PKR in Interferon Induction and Antiviral Response 2.13 0.0342 Hsp90aa1, Hsp90b1, Hspa5, Nfkbia
Endoplasmic Reticulum Stress Pathway 2.08 0.0952 Hsp90b1, Hspa5
LXR/RXR Activation 2.08 0.0331 Apod, Pltp, Srebf1, Trf
FXR/RXR Activation 2.02 0.0317 Apod, Pltp, Srebf1, Trf
TCA Cycle II (Eukaryotic) 1.97 0.0833 Dld, Sucla2
Glutamate Dependent Acid Resistance 1.88 0.5 Gad2
EIF2 Signaling 1.79 0.0223 Eif3a, Eif5, Eif5b, Hspa5, Srebf1
Gαq Signaling 1.69 0.0253 Chrm3, Nfkbia, Plcb1, Rhog
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells 1.68 0.0588 B2m, Hba-a2
eNOS Signaling 1.68 0.0252 Chrm3, Hsp90aa1, Hsp90b1, Hspa5
0X40 Signaling Pathway 1.67 0.0333 B2m, Hba-a2, Nfkbia
Regulation of Actin-based Motility by Rho 1.62 0.0319 Gsn, Pak3, Rhog
CXCR4 Signaling 1.61 0.024 Egr1, Pak3, Plcb1, Rhog
GABA Receptor Signaling 1.61 0.0316 Gabra2, Gabrb1, Gad2
Neuregulin Signaling 1.6 0.0312 Hsp90aa1, Hsp90b1, Pten
Branched-chain α-keto acid Dehydrogenase Complex 1.59 0.25 Dld
Antigen Presentation Pathway 1.57 0.0513 B2m, Hba-a2
Nitric Oxide Signaling in the Cardiovascular System 1.56 0.0303 Hsp90aa1, Hsp90b1, Pde1A
PI3K/AKT Signaling 1.55 0.0229 Hsp90aa1, Hsp90b1, Nfkbia, Pten
Sumoylation Pathway 1.52 0.0291 Nfkbia, Rhog, Senp6
PPAR Signaling 1.51 0.0288 Hsp90aa1, Hsp90b1, Nfkbia
2-ketoglutarate Dehydrogenase Complex 1.49 0.2 Dld
2-oxobutanoate Degradation I 1.49 0.2 Dld
Glutamate Degradation III (via 4-aminobutyrate) 1.49 0.2 Gad2
BAG2 Signaling Pathway 1.49 0.0465 Hsp90aa1, Hspa5
Dendritic Cell Maturation 1.49 0.0219 B2m, Hba-a2, Nfkbia, Plcb1
PD-1, PD-L1 cancer immunotherapy pathway 1.49 0.0283 B2m, Hba-a2, Pten
G-Protein Coupled Receptor Signaling 1.47 0.0184 Chrm3, Cnr1, Nfkbia, Pde1A, Plcb1
Antioxidant Action of Vitamin C 1.45 0.0275 Nfkbia, Plcb1, Selenot
PPARα/RXRα Activation 1.44 0.0211 Hsp90aa1, Hsp90b1, Nfkbia, Plcb1
iCOS-iCOSL Signaling in T Helper Cells 1.44 0.027 Hba-a2, Nfkbia, Pten
Type I Diabetes Mellitus Signaling 1.44 0.027 Gad2, Hba-a2, Nfkbia
Glycine Cleavage Complex 1.41 0.167 Dld
Natural Killer Cell Signaling 1.39 0.0203 B2m, Hba-a2, Hspa5, Pak3
Role of Tissue Factor in Cancer 1.38 0.0256 Egr1, Plcb1, Pten
TNFR1 Signaling 1.37 0.04 Nfkbia, Pak3
Thioredoxin Pathway 1.35 0.143 Selenot
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex) 1.35 0.143 Dld
Neuroinflammation Signaling Pathway 1.32 0.0167 B2m, Gabra2, Gabrb1, Gad2, Hba-a2

The most significantly affected canonical pathways after exposure included protein ubiquitination (B2m, Dnaja1, Dnajb4, Hba-a2, Hsp90aa1, Hsp90b1, Hspa4l, Hspa5, Ube2q2), aldosterone signaling in epithelial cells (Dnaja1, Dnajb4, Hsp90aa1, Hsp90b1, Hspa4l, Hspa5, Plcb1), hypoxia signaling in the cardiovascular system (Hsp90aa1, Hsp90b1, Nfkbia, Pten, Ube2q2), unfolded protein response (Hsp90b1, Hspa5, Srebf1), endoplasmic reticulum (ER) stress pathway (Hsp90b1, Hspa5), and the neuroinflammation signaling pathway (B2m, Gabra2, Gabrb1, Gad2, Hba-a2).

We observed dysregulation of genes indicative of a pro-inflammatory response, including downregulation of B2m and Hba-a2 and upregulation of Gabra2, Gabrb1, and Gad. There was significant downregulation of several genes associated with neuronal health, particularly genes involved in the integrity of the myelin sheath (Mog, Mbp, Mag, Pllp, Pmp22, Cldn11, Cnp), neurogenesis (Arc, Opalin), dendritic cell maturation (B2m, Hba-a2), NF-κB inhibition (Nfkbia, Plcb1), and learning and memory (Arc). Additionally, we found significant downregulation of mitochondrial genes coding for the F0 subunit of the proton-transporting ATP-synthase complex (mt-Atp6, mt-Atp8). There was significant upregulation of pro-apoptotic genes (Pten), genes involved in ER stress response (Hspa5, Hsp90b1), and genes involved in organonitrogen compound metabolism (Lars2, Hmgn5). There was also upregulation of genes implicated in related neurodegenerative diseases, including Oxr1, Top1, and Cdr1.

We observed dysregulation in GO categories of interest relating to biological processes, molecular functions, and cellular components. Significantly affected biological processes included leucyl-tRNA aminoacylation (Lars2), regulation of neurogenesis (Arc, Opalin), peptide metabolic process (Hmgn5, Lars2), regulation of long-term synaptic depression (Arc), regulation of postsynaptic neurotransmitter receptor internalization (Arc), and mitochondrial translation (Lars2). Notably affected GO categories involved in molecular functions included RNA strand annealing activity (Fmr1, Fxr1), supercoiled DNA binding (Psip1, Top1), and unfolded protein binding (Dnajb4, Hsp90aa1, Hsp90b1, Hspa5). Significantly affected GO categories forming cellular components of interest included the myelin sheath (Cldn11, Cnp, Dld, Gjc2, Gsn, Hsp90aa1, Hspa5, Mag, Mbp, Mog, Plcb1, Sucla2), GABAergic synapses (Camk4, Cnr1, Gabra2, Gabrb1, Gabrd, Nrxn1, Plcb1, Slc6a6), dendritic spines (Akap5, Arc, Fmr1, Fxr1, Homer1, Lpar1, Mob4, Pten, Slc8a1, Syndig1), ER chaperone complex (Hsp90b1, Hspa5, Sdf2l1), MHC class I peptide loading complex (B2m, H2-D1, H2-K1), and endocytic vesicles (Gsn, Kif5b, Lpar1, Nrxn1, Rab8b, Rab9b, Rabep1, Trf), among others.

4. Discussion

Our results showed that subcutaneous administration of PB + CPF + DEET for two weeks induced acute changes in gene expression in mouse hippocampal tissue, including dysregulation of genes indicating a pro-inflammatory response, downregulation of genes associated with neuronal health, and upregulation of pro-apoptotic genes, genes involved in ER stress response, and genes implicated in neurogenerative diseases, among others. We also observed significant effects of our Gulf War exposure on spatial memory.

The three most significantly downregulated genes after exposure were Arc, Egr1, and Nr4a1, all of which are neuronal immediate early genes (IEGs). Arc is predominantly expressed in cortical and hippocampal glutamatergic neurons and is involved in numerous neuronal signaling pathways [20,21]. Arc knockout mice display deficits in long-term memory formation in implicit and explicit learning tasks and impaired long-term potentiation (LTP) and depression (LTD) [22]; similar effects on LTP and spatial learning were shown in rats after chemical inhibition of Arc [23]. Egr1 is required for stabilization of synaptic plasticity in the hippocampus as well as formation of both hippocampal and non-hippocampal-dependent long-term memory [24] and is a direct transcriptional regulator of Arc [25].

Although IEGs are classified as such due to their early and transient response to environmental stimuli, both Arc and Egr1 also play critical roles in mediating the structural changes that underlie neuronal and synaptic plasticity, suggesting that their dysregulation could trigger long-term morphological changes with negative impacts on learning and memory formation. Several mouse models of Alzheimer’s disease (AD) report early dysregulation of IEGs involved in LTP and synaptic plasticity [26]. Dickey et al. observed a significant decrease in basal Arc, Egr1, and Nr4a1 expression in amyloid-containing hippocampus and cortex of APP/PS1 transgenic mice [27]. Levels of basal and exploration-induced Arc expression are significantly reduced in granule cells of the dentate gyrus of hAPPFAD transgenic mice [28]. Induced Arc expression was also dysregulated in the CA3 region and dentate gyrus of rats chronically infused with lipopolysaccharide (LPS) to induce neuroinflammation, suggesting altered patterns of Arc expression may contribute to cognitive and memory impairments in neurodegeneration [29]. IEGs have been investigated as a potential therapeutic target in AD treatment [30,31].

IEGs such as Arc and Egr1 have also been suggested to play a critical role in the interaction between genes and environment to determine the risk of developing psychiatric illness, particularly major depressive disorder (MDD), which is typically comorbid with GWI [17,3235]. Chronic treatment with various antidepressants targeting serotonin and norepinephrine can also restore Arc expression in the hippocampus and prefrontal cortex [36,37].

Additionally, Arc inhibits the binding of heat shock factor 1 (HSF1) to the heat shock element (HSE) in heat shock protein (HSP) gene promoters and prevents activation of HSP genes [38]. Accordingly, we observed upregulation of Hsp genes, including Hsp40s (Dnajb4, Dnaja1), Hsp70s (Hspa4l, Hspa5), and Hsp90s (Hsap90aa1, Hsp90b1) and found that these genes were involved in several significantly affected pathways, including protein ubiquitination, aldosterone signaling, hypoxia signaling, unfolded protein response, interferon induction and antiviral response, and the ER stress pathway, among others. Thus, dysregulation of IEGs may play a role in acute neuroinflammation, leading to chronic neurodegeneration.

Interestingly, several genes encoding proteins that are structural components of myelin were downregulated, including Mbp, Mag, Mog, and Cnp. Myelin basic protein (Mbp) is phosphorylated by MAP kinase in response to action potential firing during LTP in the hippocampus [39,40]. Plasma autoantibodies against Mbp have also been found to be significantly increased in Veterans with symptoms of GWI compared to healthy controls [41,42]. We also observed dysregulation of genes related to the GABAergic synapse, including Camk4, Cnr1, Gabra2, Gabrb1, Gabrd, Nrxn1, Plcb1, and Slc6a6. Chronically, decreased GABA has been reported in hippocampi of mice exposed to PB + permethrin + DEET three months after exposure [43]. Additionally, we found decreased expression of Chrm3, which codes for the M3 muscarinic receptor. Decreased M3 receptor density has been reported in the CA1 region, CA3 region, and molecular layer of the hippocampus in C57Bl/6 mice exposed to PB + stress [44]. This suggests that changes in GABAA and M3 receptor expression may begin during the acute phase of chronic sublethal exposure to our Gulf War toxicants.

Reported dosages and routes of administration of Gulf War toxicants in rodent models have varied widely throughout the literature. The subcutaneous route of administration for exposure to PB + CPF + DEET has several advantages. PB was taken orally by military personnel and is frequently administered via gavage in animal models; however, PB has been shown to have poor bioavailability, suggesting that injection may deliver a more precise dosage [45]. There has also been a significant amount of investigation into the effects of stress in combination with PB and other toxicants, with results that indicate increased BBB permeability to toxicants in stressed animals [46]. Friedman et al. reported significant effects of PB + stress on levels of c-Fos and AChE mRNAs in mouse whole-brain homogenates, indicating that stress can be a confounding variable in gene expression data examining an early transcriptional response [47]. The subcutaneous route would not present potential stress from repeated oral gavage.

Subcutaneous administration also avoids variable absorption via dermal application of CPF and DEET, which would have been in contact with the skin of military personnel. A study by Keil et al. examining the immunotoxicology of DEET in female B6C3F1 mice elaborated on factors which are necessary to accurately compare exposures in animal models but are often not considered [48]. Many human and animal studies refer to dermal penetration rather than absorption into the bloodstream, which is not an equivalent measure due to the variability of absorption levels within and between species. Keil et al. reported that s.c. administration of 7.7 mg/kg/day DEET equates to an estimated mouse blood exposure level that encompasses estimated military exposure levels as well as estimated DEET usage by the general population. Additionally, Keil et al. argue that the emphasis placed on relevant route of exposure in the literature has limited utility, particularly in the case of dermal exposures such as DEET or CPF. CPF, a lipophilic organophosphate, could accumulate within the brain to cause AChE inhibition at our acute timepoint, which could have an effect on behavioral outcomes. There are wide ranges of estimated absorption and metabolic rates between rodents and humans.

It should be noted that military personnel would have been exposed to these compounds at lower dosages, but this exposure occurred over longer periods of time. In rodent models, higher dosages are often used in a shorter time frame due to the lifespan of the animal and the window in which to study effects. Other studies have reported using similar dosages at these intervals: Lamproglou et al. reported i.o. administration of 1.5 mg/kg PB for 12 days (5 days on, 2 days off, 5 days on) in male Wistar rats [49]; Peden-Adams et al. treated female B6C3F1 mice treated with 15.5 mg/kg DEET, 2 mg/kg PB, and 500 mg/kg JP-8 s.c. for 14 days as a “low dose” group [50]; Torres-Altoro et al. reported treatment of female C57Bl/6 mice with 30 mg/kg CPF s.c. for 7 days, male FVB mice with 2.5 mg/kg PB + 5 mg/kg DEET s.c. for 15 days, and male C57Bl/6 treated with 1 mg/kg PB s.c. for 10 days [51]; and Mauck et al. treated male C57Bl/6 mice with 3 or 10 mg/kg PB for 7 days via s.c. ALZET pump [44]. These studies illustrate the similar range of concentrations over shorter time frames, as well as the potential advantages of s.c. administration for certain experiments.

Whole transcriptome sequencing has been used previously in several rodent models of Gulf War exposure. A similar study by Shetty et al. examined changes in gene expression using qRT-PCR after 4 weeks of exposure to PB + DEET + stress in male Sprague-Dawley rats; however, their samples, collected at a longer 6-month time point after the last exposure, presented a gene expression profile indicative of chronic neuroinflammation [16]. Gene expression profiles of GWI patients have also been studied to identify novel treatment strategies by examining the overlap of dysregulated genes with drug targets and in comparison with expression profiles of other diseases [52]. In contrast, our acute Gulf War exposure model shows early effects that do not appear in chronic exposure models, such as dysregulation of IEGs. Xu et al. also recently reported on acute transcriptional changes in BXD mouse strains after exposure to corticosterone + diisopropyl fluorophosphate (DFP) [19]. We believe that acute changes may prime chronic neurodegenerative processes; therefore, further research should investigate mechanistic connections between early responses to toxicant exposure and chronic symptoms, including memory deficits, mood disorders, and neurodegeneration.

5. Conclusion

This study provides an assessment of changes in gene expression in combined exposure to PB, CPF, and DEET and a unique gene expression profile at an acute timepoint. Many of the dysregulated genes involve inflammatory signaling and other pathways that are important for the health of neurons. The neurological effects of toxicants, including memory deficits, may begin soon after exposure, and future research will further define the way these responses increase with time due to aging and other influences.

Acknowledgments

We thank Julia A. Burton and Mihal Grinberg for their expert technical assistance and Joshua Karp, Shannon Clare, Elizabeth Chang, and Gabrielle Gallant for their input. We also thank the Rutgers-NJMS Genomics Center (Drs. Patricia Soteropoulos and Mainul Hoque) for RNA-Seq processing and advice. This study was supported by the Department of Veterans Affairs (Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development (I01RX001520 and IK2RX003253) and Biomedical Laboratory Research and Development (I21BX003514)), the Assistant Secretary of Defense for Health Affairs through the Congressionally Directed Gulf War Illness Research Program (W81XWH-16-1-0626), the War Related Illness and Injury Study Center (NJ), the Bay Pines Foundation, and the Veterans Bio-Medical Research Institute. The data discussed in this publication have been deposited in NCBI’s Gene Expression Omnibus (Edgar et al., 2002) and are accessible through GEO Series accession number GSE180786 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180786).

Footnotes

Declaration of competing interest

No competing financial interests exist. The contents do not represent the views of the Department of Veterans Affairs or the United States Government, and the opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.

References

  • [1].Institute of Medicine [IOM], Gulf War and Health: Volume 8: Update of Health Effects of Serving in the Gulf War, Washington, D.C, 2010. [PubMed] [Google Scholar]
  • [2].Institute of Medicine [IOM], Chronic Multisymptom Illness in Gulf War Veterans: Case Definitions Reexamined, Washington, D.C, 2014. [PubMed] [Google Scholar]
  • [3].United States Department of Veterans Affairs, Research Advisory Committee on Gulf War Veterans&apos; Illnesses [RAC-GWI], Gulf War Illness and the Health of Gulf War Veterans: Scientific Findings and Recommendations, Washington, D.C, 2008. [Google Scholar]
  • [4].Institute of Medicine [IOM], Gulf War Veterans: Treating Symptoms and Syndromes, Washington, D.C, 2001. [PubMed] [Google Scholar]
  • [5].Institute of Medicine [IOM], Gulf War and Health: Treatment for Chronic Multisymptom Illness, Washington, D.C, 2013. [PubMed] [Google Scholar]
  • [6].Steele L, Prevalence and patterns of gulf war illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service, Am. J. Epidemiol 152 (2000) 992–1002, 10.1093/aje/152.10.992. [DOI] [PubMed] [Google Scholar]
  • [7].White RF, Steele L, O’Callaghan JP, Sullivan K, Binns JH, Golomb BA, Bloom FE, Bunker JA, Crawford F, Graves JC, Hardie A, Klimas N, Knox M, Meggs WJ, Melling J, Philbert MA, Grashow R, Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: effects of toxicant exposures during deployment, Cortex 74 (2016) 449–475, 10.1016/j.cortex.2015.08.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Dickey B, Madhu LN, Shetty AK, Gulf war illness: mechanisms underlying brain dysfunction and promising therapeutic strategies, Pharmacol. Ther 107716 (2020), 10.1016/j.pharmthera.2020.107716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [9].Parihar VK, Hattiangady B, Shuai B, Shetty AK, Mood and memory deficits in a model of gulf war illness are linked with reduced neurogenesis, partial neuron loss, and mild inflammation in the hippocampus, Neuropsychopharmacology 38 (2013) 2348–2362, 10.1038/npp.2013.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Chaney LA, Rockhold RW, Mozingo JR, Hume AS, Moss JI, Potentiation of pyridostigmine bromide toxicity in mice by selected adrenergic agents and caffeine, Vet. Hum. Toxicol 39 (1997) 214–219. [PubMed] [Google Scholar]
  • [11].Chaney LA, Wineman RW, Rockhold RW, Hume AS, Acute effects of an insect repellent, N, N-diethyl-m-toluamide, on cholinesterase inhibition induced by pyridostigmine bromide in rats, Toxicol. Appl. Pharmacol 165 (2000) 107–114, 10.1006/taap.2000.8936. [DOI] [PubMed] [Google Scholar]
  • [12].Prendergast MA, Terry AV Jr., Buccafusco JJ, Chronic, low-level exposure to diisopropylfluorophosphate causes protracted impairment of spatial navigation learning, Psychopharmacology 129 (1997) 183–191, 10.1007/s002130050179. [DOI] [PubMed] [Google Scholar]
  • [13].Terry AV Jr., Stone JD, Buccafusco JJ, Sickles DW, Sood A, Prendergast MA, Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning, J. Pharmacol. Exp. Ther 305 (2003) 375–384, 10.1124/jpet.102.041897. [DOI] [PubMed] [Google Scholar]
  • [14].Abou-Donia MB, Wilmarth KR, Abdel-Rahman AA, Jensen KF, Oehme FW, Kurt TL, Increased neurotoxicity following concurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos, Fundam. Appl. Toxicol 34 (1996) 201–222, 10.1006/faat.1996.0190. [DOI] [PubMed] [Google Scholar]
  • [15].Ojo JO, Abdullah L, Evans J, Reed JM, Montague H, Mullan MJ, Crawford FC, Exposure to an organophosphate pesticide, individually or in combination with other gulf war agents, impairs synaptic integrity and neuronal differentiation, and is accompanied by subtle microvascular injury in a mouse model of gulf war agent exposure, Neuropathology 34 (2014) 109–127, 10.1111/neup.12061. [DOI] [PubMed] [Google Scholar]
  • [16].Shetty GA, Hattiangady B, Upadhya D, Bates A, Attaluri S, Shuai B, Kodali M, Shetty AK, Chronic oxidative stress, mitochondrial dysfunction, Nrf2 activation and inflammation in the hippocampus accompany heightened systemic inflammation and oxidative stress in an animal model of gulf war illness, Front. Mol. Neurosci 10 (2017) 182, 10.3389/fnmol.2017.00182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Pierce LM, Kurata WE, Matsumoto KW, Clark ME, Farmer DM, Long-term epigenetic alterations in a rat model of gulf war illness, Neurotoxicology 55 (2016) 20–32, 10.1016/j.neuro.2016.05.007. [DOI] [PubMed] [Google Scholar]
  • [18].Ashbrook DG, Hing B, Michalovicz LT, Kelly KA, Miller JV, de Vega WC, Miller DB, Broderick G, O’Callaghan JP, McGowan PO, Epigenetic impacts of stress priming of the neuroinflammatory response to sarin surrogate in mice: a model of gulf war illness, J. Neuroinflammation 15 (2018) 86, 10.1186/s12974-018-1113-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Xu F, Ashbrook DG, Gao J, Starlard-Davenport A, Zhao W, Miller DB, O’Callaghan JP, Williams RW, Jones BC, Lu L, Genome-wide transcriptome architecture in a mouse model of gulf war illness, Brain Behav. Immun 89 (2020) 209–223, 10.1016/j.bbi.2020.06.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Epstein I, Finkbeiner S, The arc of cognition: signaling cascades regulating arc and implications for cognitive function and disease, Semin. Cell Dev. Biol 77 (2018) 63–72, 10.1016/j.semcdb.2017.09.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Korb E, Finkbeiner S, Arc in synaptic plasticity: from gene to behavior, Trends Neurosci 34 (2011) 591–598, 10.1016/j.tins.2011.08.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Plath N, Ohana O, Dammermann B, Errington ML, Schmitz D, Gross C, Mao X, Engelsberg A, Mahlke C, Welzl H, Kobalz U, Stawrakakis A, Fernandez E, Waltereit R, Bick-Sander A, Therstappen E, Cooke SF, Blanquet V, Wurst W, Salmen B, Bosl MR, Lipp HP, Grant SG, Bliss TV, Wolfer DP, Kuhl D, Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories, Neuron 52 (2006) 437–444, 10.1016/j.neuron.2006.08.024. [DOI] [PubMed] [Google Scholar]
  • [23].Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA, Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory, J. Neurosci 20 (2000) 3993–4001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Jones MW, Errington ML, French PJ, Fine A, Bliss TV, Garel S, Charnay P, Bozon B, Laroche S, Davis S, A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories, Nat. Neurosci 4 (2001) 289–296, 10.1038/85138. [DOI] [PubMed] [Google Scholar]
  • [25].Li L, Carter J, Gao X, Whitehead J, Tourtellotte WG, The neuroplasticity-associated arc gene is a direct transcriptional target of early growth response (Egr) transcription factors, Mol. Cell. Biol 25 (2005) 10286–10300, 10.1128/MCB.25.23.10286-10300.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Perusini JN, Cajigas SA, Cohensedgh O, Lim SC, Pavlova IP, Donaldson ZR, Denny CA, Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer&apos;s disease mice, Hippocampus 27 (2017) 1110–1122, 10.1002/hipo.22756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Dickey CA, Loring JF, Montgomery J, Gordon MN, Eastman PS, Morgan D, Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein presenilin-1 transgenic mice, J. Neurosci 23 (2003) 5219–5226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Palop JJ, Chin J, Bien-Ly N, Massaro C, Yeung BZ, Yu GQ, Mucke L, Vulnerability of dentate granule cells to disruption of arc expression in human amyloid precursor protein transgenic mice, J. Neurosci 25 (2005) 9686–9693, 10.1523/JNEUROSCI.2829-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Rosi S, Ramirez-Amaya V, Vazdarjanova A, Worley PF, Barnes CA, Wenk GL, Neuroinflammation alters the hippocampal pattern of behaviorally induced arc expression, J. Neurosci 25 (2005) 723–731, 10.1523/JNEUROSCI.4469-04.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [30].Perry KW, Nisenbaum LK, George CA, Shannon HE, Felder CC, Bymaster FP, The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex, Biol. Psychiatry 49 (2001) 716–725, 10.1016/s0006-3223(00)01017-9. [DOI] [PubMed] [Google Scholar]
  • [31].Tong XK, Lecrux C, Rosa-Neto P, Hamel E, Age-dependent rescue by simvastatin of Alzheimer&apos;s disease cerebrovascular and memory deficits, J. Neurosci 32 (2012) 4705–4715, 10.1523/JNEUROSCI.0169-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Gallitano AL, Editorial: the role of immediate early genes in neuropsychiatric illness, Front. Behav. Neurosci 14 (2020) 16, 10.3389/fnbeh.2020.00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Duclot F, Kabbaj M, The role of early growth response 1 (EGR1) in brain plasticity and neuropsychiatric disorders, Front. Behav. Neurosci 11 (2017) 35, 10.3389/fnbeh.2017.00035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Xu Y, Pan J, Sun J, Ding L, Ruan L, Reed M, Yu X, Klabnik J, Lin D, Li J, Chen L, Zhang C, Zhang H, O’Donnell JM, Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress, Neurobiol. Aging 36 (2015) 955–970, 10.1016/j.neurobiolaging.2014.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Covington HE 3rd, Lobo MK, Maze I, Vialou V, Hyman JM, Zaman S, LaPlant Q, Mouzon E, Ghose S, Tamminga CA, Neve RL, Deisseroth K, Nestler EJ, Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex, J. Neurosci 30 (2010) 16082–16090, 10.1523/JNEUROSCI.1731-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Gallo FT, Katche C, Morici JF, Medina JH, Weisstaub NV, Immediate early genes, memory and psychiatric disorders: focus on c-fos, Egr1 and arc, Front. Behav. Neurosci 12 (2018) 79, 10.3389/fnbeh.2018.00079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Li Y, Pehrson AL, Waller JA, Dale E, Sanchez C, Gulinello M, A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)& apos;s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression, Front. Neurosci 279 (2015), 10.3389/fnins.2015.00279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Park AY, Park YS, So D, Song IK, Choi JE, Kim HJ, Lee KJ, Activity-regulated cytoskeleton-associated protein(Arc/Arg3.1) is transiently expressed after heat shock stress and suppresses heat shock factor 1, Sci. Rep 9 (2019) 2592, 10.1038/s41598-019-39292-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Atkins CM, Yon M, Groome NP, Sweatt JD, Regulation of myelin basic protein phosphorylation by mitogen-activated protein kinase during increased action potential firing in the hippocampus, J. Neurochem 73 (1999) 1090–1097, 10.1046/j.1471-4159.1999.0731090.x. [DOI] [PubMed] [Google Scholar]
  • [40].Lee PR, Fields RD, Regulation of myelin genes implicated in psychiatric disorders by functional activity in axons, Front. Neuroanat 3 (2009) 4, 10.3389/neuro.05.004.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Abou-Donia MB, Conboy LA, Kokkotou E, Jacobson E, Elmasry EM, Elkafrawy P, Neely M, Bass CR, Sullivan K, Screening for novel central nervous system biomarkers in veterans with gulf war illness, Neurotoxicol. Teratol 61 (2017) 36–46, 10.1016/j.ntt.2017.03.002. [DOI] [PubMed] [Google Scholar]
  • [42].Abou-Donia MB, Lapadula ES, Krengel MH, Quinn E, LeClair J, Massaro J, Conboy LA, Kokkotou E, Abreu M, Klimas NG, Nguyen DD, Sullivan K, Using plasma autoantibodies of central nervous system proteins to distinguish veterans with gulf war illness from healthy and symptomatic controls, Brain Sci 10 (2020), 10.3390/brainsci10090610. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • [43].Carreras I, Aytan N, Mellott T, Choi JK, Lehar M, Crabtree L, Leite-Morris K, Jenkins BG, Blusztajn JK, Dedeoglu A, Anxiety, neuroinflammation, cholinergic and GABAergic abnormalities are early markers of gulf war illness in a mouse model of the disease, Brain Res 1681 (2018) 34–43, 10.1016/j.brainres.2017.12.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Mauck B, Lucot JB, Paton S, Grubbs RD, Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice, Neurotoxicology 31 (2010) 461–467, 10.1016/j.neuro.2010.06.001. [DOI] [PubMed] [Google Scholar]
  • [45].Abdullah L, Crynen G, Reed J, Bishop A, Phillips J, Ferguson S, Mouzon B, Mullan M, Mathura V, Mullan M, Ait-Ghezala G, Crawford F, Proteomic CNS profile of delayed cognitive impairment in mice exposed to gulf war agents, Neuromolecular Med 13 (2011) 275–288, 10.1007/s12017-011-8160-z. [DOI] [PubMed] [Google Scholar]
  • [46].Abdel-Rahman A, Shetty AK, Abou-Donia MB, Disruption of the blood-brain barrier and neuronal cell death in cingulate cortex, dentate gyrus, thalamus, and hypothalamus in a rat model of gulf-war syndrome, Neurobiol. Dis 10 (2002) 306–326, 10.1006/nbdi.2002.0524. [DOI] [PubMed] [Google Scholar]
  • [47].Friedman A, Kaufer D, Shemer J, Hendler I, Soreq H, Tur-Kaspa I, Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response, Nat. Med 2 (1996) 1382–1385, 10.1038/nm1296-1382. [DOI] [PubMed] [Google Scholar]
  • [48].Keil DE, McGuinn WD, Dudley AC, EuDaly JG, Gilkeson GS, Peden-Adams MM, N, N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice, Toxicol. Sci 108 (2009) 110–123, 10.1093/toxsci/kfp001. [DOI] [PubMed] [Google Scholar]
  • [49].Lamproglou I, Barbier L, Diserbo M, Fauvelle F, Fauquette W, Amourette C, Repeated stress in combination with pyridostigmine part I: long-term behavioural consequences, Behav. Brain Res 197 (2009) 301–310, 10.1016/j.bbr.2008.08.031. [DOI] [PubMed] [Google Scholar]
  • [50].Peden-Adam MM, Eudaly J, Eudaly E, Dudley A, Zeigler J, Lee A, Robbs J, Gilkeson G, Keil DE, Evaluation of immunotoxicity induced by single or concurrent exposure to N, N-diethyl-m-toluamide (DEET), pyridostigmine bromide (PYR), and JP-8 jet fuel, Toxicol. Ind. Health 17 (2001) 192–209, 10.1191/0748233701th120oa. [DOI] [PubMed] [Google Scholar]
  • [51].Torres-Altoro MI, Mathur BN, Drerup JM, Thomas R, Lovinger DM, O’Callaghan JP, Bibb JA, Organophosphates dysregulate dopamine signaling, glutamatergic neurotransmission, and induce neuronal injury markers in striatum, J. Neurochem 119 (2011) 303–313, 10.1111/j.1471-4159.2011.07428.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Craddock TJ, Harvey JM, Nathanson L, Barnes ZM, Klimas NG, Fletcher MA, Broderick G, Using gene expression signatures to identify novel treatment strategies in gulf war illness, BMC Med. Genet 8 (2015) 36, 10.1186/s12920-015-0111-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES